INJECTION INDEXWeight management, clearly.
The online care edition
October 2026
The plan index · October 2026

Tirzepatide Plans and Product Information

Compare a prescription pathway without confusing a compounded preparation with a brand.

Read this firstSources checked October 7, 2026

Compare the actual tirzepatide product first, then the care and pharmacy costs around it.

Tirzepatide 5 mg
15%

Randomized study arm; not a dosing recommendation.

Tirzepatide 10 mg
19.5%

Randomized study arm; not a dosing recommendation.

Tirzepatide 15 mg
20.9%

Randomized study arm; not a dosing recommendation.

Tirzepatide is used in an approved branded medicine and in some advertised compounded preparations. The ingredient headline cannot by itself identify the prescribed product or its approval status. Ask for the exact product, route, and clinical rationale before comparing an enrollment price.

This page brings together the CoreAge compounded starting offer, other care models, and official Zepbound information. A branded product page is not a clinic quote. The care provider, pharmacy expense, and required monitoring must be evaluated for the actual treatment proposed.

02

SuperHealthy Rx

Compounded GLP-1 care

Publisher score 9.7/10

The offer

Compounded tirzepatide on the dedicated promotion

A current-source review of SuperHealthy Rx GLP-1 care: a written plan that can be compared fairly, billing questions and evidence limits.

Open the complete review →
Advertised price$135/mo promoVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

03

Likeness Rx

Compounded semaglutide or tirzepatide

Publisher score 9.5/10

The offer

Tirzepatide: $1,548 annual term; $199 month-to-month

Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.

Open the complete review →
Advertised price$129/mo equivalentVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

04

Ro

Introductory membership
The offer

Membership and medication billed separately

Ro separates the cost of its care membership from the prescription cost.

Open the complete review →
Advertised price$39 startVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

05

Mochi Health

Membership only
The offer

Ongoing membership; medication costs extra

Mochi’s recurring membership and medicine charges need to be read together.

Open the complete review →
Advertised price$79/moVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

06

Found

Insurance, cash pay or compounded plan
The offer

Insured and cash-pay pathways; selected plan determines total

Found offers more than one treatment and payment pathway, so a personalized quote is essential.

Open the complete review →
Advertised pricePlan variesVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

07

Zepbound

Branded medicine
The offer

Manufacturer medicine information; not a clinic

Zepbound’s manufacturer record identifies tirzepatide, weight-management and specific sleep-apnea uses; savings routes and care access are separate from the medicine itself.

Open the complete review →
Advertised priceOffer variesVisit provider ↗
What to compare

Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.

The details, visualized

Tirzepatide evidence anchor: SURMOUNT-1

Mean reduction from baseline body weight (%)

  1. Tirzepatide 5 mg15%

    Randomized study arm; not a dosing recommendation.

  2. Tirzepatide 10 mg19.5%

    Randomized study arm; not a dosing recommendation.

  3. Tirzepatide 15 mg20.9%

    Randomized study arm; not a dosing recommendation.

  4. Placebo3.1%

    Lifestyle intervention accompanied the trial.

Group averages, not individual predictions. Doses identify trial arms, not dosing advice. These data do not establish outcomes for compounded preparations. Bars start at zero.

View the printable chart imageTirzepatide evidence anchor: SURMOUNT-1. The same values and context are available in the data table above.
Research note 01

A result from a trial is not a result from a storefront

SURMOUNT-1 studied specified weekly tirzepatide regimens over 72 weeks. Its dose-group results are presented as research context, not a ladder for choosing treatment or a score assigned to the listed providers. A clinician determines the appropriate product and regimen.

A compounded tirzepatide offer is distinct from branded Zepbound. Request the exact preparation, dispensing pharmacy and full invoice. If a program describes branded access, establish whether its price is a membership, an insurer copay, a manufacturer offer or a pharmacy charge.

Before you decide

Questions worth answering

Does the order on this page identify the best treatment for me?

No. It is a publisher-arranged comparison of selected public offers. The chart explains the specific purchase or evidence question; a licensed clinician must assess the actual treatment.

What should I verify for this comparison?

Compare the actual tirzepatide product first, then the care and pharmacy costs around it. Ask for the selected written quote and the product-specific clinical explanation before making a purchase.

Evidence behind this page

Sources & chart notes

Checked October 7, 2026. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.

Editorial illustration: an unbranded container, information sheet and magnifying glass.
Tirzepatide Plans and Product Information — keep the exact product identity and its complete label together.

Keep the brand and ingredient separate

Zepbound is an FDA-approved branded product. A compounded tirzepatide preparation is not Zepbound and should not be evaluated as an approved generic substitute. The official product profile and product distinction guide help identify the correct discussion.

Editorial illustration: an unbranded container, information sheet and magnifying glass.
Keep the brand and ingredient separate — keep the exact product identity and its complete label together.

Tie the price to the prescription

CoreAge advertises compounded tirzepatide from $129 per month. Other programs can separate care membership and medicine expenses. Confirm the ongoing invoice and pharmacy product rather than using a semaglutide promotion to estimate a tirzepatide bill.

Ask how the plan is reviewed

Treatment suitability and changes belong with the clinician. Find out how medical concerns are communicated and how refills are assessed. Read the clinical checklist before choosing from a product comparison.

Explore the review directory and full cost table to compare the details of another offer.

Research record

Documents used

Source register refreshed October 7, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.

  1. FDA: Concerns about unapproved GLP-1 drugs ↗
  2. NIDDK: Prescription medicines for weight management ↗
  3. Wegovy: Official product information ↗
  4. Zepbound: Official product information ↗